Verdad Advisers »

Foghorn Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $117k 24k 4.78

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
FMR
BVF
Deerfield Management Company
Raymond James Financial
BlackRock
Euclidean Capital
Vanguard Capital Management
Geode Capital Management
Siren
State Street Corporation
Ameriprise Financial
Renaissance Technologies
Candriam Luxembourg S.C.A.
Jacobs Levy Equity Management

View all funds holding Foghorn Therapeutics